| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |